(Q37827157)

23 August 2017

1 reference

title

Current advances in cell therapy strategies for muscular dystrophies (English)

1 reference

23 August 2017

Elisa Negroni

1

0 references

Capucine Trollet

Capucine Trollet

6

0 references

Jean-Thomas Vilquin

Jean-Thomas Vilquin

3

0 references

Vincent Mouly

Vincent Mouly

5

0 references

Gillian Butler-Browne

Gillian Butler-Browne

4

0 references

author name string

Denis Vallese

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

Expert Opinion on Biological Therapy

23 August 2017

published in

1 reference

23 August 2017

volume

11

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

157-176

1 reference

Retrospective birth dating of cells in humans

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Interventions for muscular dystrophy: molecular medicines entering the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

The dystrophin-associated glycoprotein complex: what parts can you do without?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Pharmacological strategies for muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Regenerative pharmacology in the treatment of genetic diseases: the paradigm of muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

RNA-targeting approaches for neuromuscular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Gene therapy for muscular dystrophy: current progress and future prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Progress and prospects: immune responses to viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Stem cell based therapies to treat muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Satellite cell of skeletal muscle fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

21 January 2018

Muscle satellite cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

The skeletal muscle satellite cell: the stem cell that came in from the cold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

An analysis of nuclear numbers in individual muscle fibers during differentiation and growth: A satellite cell-muscle fiber growth unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Regenerative potential of human skeletal muscle during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Are human and mouse satellite cells really the same?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

New multiple labelling method for improved satellite cell identification in human muscle: application to a cohort of power-lifters and sedentary men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Heterogeneity in the progeny of single human muscle satellite cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Arterial delivery of myoblasts to skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Asymmetric self-renewal and commitment of satellite stem cells in muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Direct isolation of satellite cells for skeletal muscle regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Self-renewal and expansion of single transplanted muscle stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Cell Therapy of -Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

A perivascular origin for mesenchymal stem cells in multiple human organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Sox2 transduction enhances cardiovascular repair capacity of blood-derived mesoangioblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Acceleration of skeletal muscle regeneration in a rat skeletal muscle injury model by local injection of human peripheral blood-derived CD133-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

"Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

The contribution of human synovial stem cells to skeletal muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Propagation and maintenance of undifferentiated human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Derivation of engraftable skeletal myoblasts from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Pluripotency of embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Generation of mouse induced pluripotent stem cells without viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Embryonic stem cell-specific microRNAs promote induced pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Disease-specific induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Patient-specific pluripotent stem cells become even more accessible

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Engraftment of embryonic stem cell-derived myogenic progenitors in a dominant model of muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Expression of dog microdystrophin in mouse and dog muscles by gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Autologous transplantation of SM/C-2.6(+) satellite cells transduced with micro-dystrophin CS1 cDNA by lentiviral vector into mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Complete genetic correction of ips cells from Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Dystrophin expression in host muscle following transplantation of muscle precursor cells modified with the phiC31 integrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Immortalized Skin Fibroblasts Expressing Conditional MyoD as a Renewable and Reliable Source of Converted Human Muscle Cells to Assess Therapeutic Strategies for Muscular Dystrophies: Validation of an Exon-Skipping Approach to Restore Dystrophin in D

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skipping

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Meganucleases can restore the reading frame of a mutated dystrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Real-time monitoring of cell transplantation in mouse dystrophic muscles by a secreted alkaline phosphatase reporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Discrepancies between the fate of myoblast xenograft in mouse leg muscle and NMR label persistency after loading with Gd-DTPA or SPIOs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Mammalian animal models for Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Animal models for genetic neuromuscular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Animal models for muscular dystrophy: valuable tools for the development of therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Canine and feline models of human inherited muscle diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

X chromosome-linked muscular dystrophy (mdx) in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Mutations in mice that influence natural killer (NK) cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Myoblast transfer in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Correlation of circulating CD133+ progenitor subclasses with a mild phenotype in Duchenne muscular dystrophy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Demonstration of a splenic cytotoxic effector cell in mice of genotype SCID/SCID.BG/BG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Extended Amplification In Vitro and Replicative Senescence: Key Factors Implicated in the Success of Human Myoblast Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Very efficient myoblast allotransplantation in mice under FK506 immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

A Novel Immunodeficient Mouse Model-RAG2 gamma Cytokine Receptor Chain Double Mutants-Requiring Exogenous Cytokine Administration for Human Hematopoietic Stem Cell Engraftment Common

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Comparative Analysis of Genetically Engineered Immunodeficient Mouse Strains as Recipients for Human Myoblast Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Evidence of fusion between host and donor myoblasts in skeletal muscle grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

Absence of Thymus in a Mouse Mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2011.542748

10.1517/14712598.2011.542748

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference